Skip to main content
Caplight Logo









Genopore

Genopore

Private
IsraelHealthcare & Life Scienceshttps://www.genopore.com/

Last Round

Seed

Nov 6, 2022

Total Funding Raised

$2.74M

Company Overview

Genopore is a biotechnology company developing a digital protein identification and quantification system that leverages direct optical detection at the single-molecule level.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment, Semiconductors

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

proteomicsnanopore sequencingsingle-molecule analysisprotein identificationbiosensingprecision medicinedrug discoverynanopore technologyprotein quantificationnext-gen proteomicsbiotech equipmentsemiconductor biosensorAI-powered diagnosticsmass spec alternativesingle-cell proteomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genopore Comparables

Compare Genopore with similar companies based on industry and business-model similarity.

Genopore comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Erisyon
86%
Glyphic Biotechnologies
84%
Encodia
78%

Genopore Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 6, 2022

Key People

Founding team and executive leadership

Aviv Sagi

CFO

Executive Team

Ariel Notcovich

Chief Product Officer

Executive Team

Genopore Investors

Notable investors and investment history

Genopore investors
InvestorRounds
M VenturesSeed
imec.xpandSeed
M VenturesSeed

Recent news

Latest coverage and updates

  • hiresJul 14, 2026

    Genopore hired Rey Mali as Chief Executive Officer on Jul 14th '26.

Genopore Filings

Explore SEC and related filing metadata, where available.

Genopore filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genopore's valuation, stock price, and market status.

Is Genopore a public or private company?

Genopore is a private company.

What is the current stock price of Genopore?

Genopore is a private company with no public stock price. No recent secondary market data is available.

How much is Genopore worth (valuation)?

Valuation information for Genopore is not publicly available.

Can I buy Genopore stock?

Genopore shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genopore's last funding round?

Genopore's most recent funding round was Seed on November 6, 2022.

Who are the main investors in Genopore?

Key investors in Genopore include M Ventures.

Will Genopore IPO soon?

No public IPO plans have been announced for Genopore.

How can I track Genopore secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genopore's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range13
Year Founded2020
Last FundingNov 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?